1713. Novel Immunotherapies: What the ID Provider Needs to Know
Session: Symposium: The Future of Transplant ID: Novel Diagnostics and Therapeutics
Saturday, October 6, 2018: 9:10 AM
Room: S 214-216
Jay Fishman, MD, FIDSA, I D Unit, Massachusetts General Hospital, Boston, MA

Jay A. Fishman is Director of the Transplant Infectious Diseases and Compromised Host Program at the Massachusetts General Hospital (MGH), Associate Director of the MGH Transplant Center, and Professor of Medicine at Harvard Medical School. Dr. Fishman is an internationally recognized expert in infectious diseases related to transplantation and has trained many of the leaders in this field. He has a special interest in molecular diagnostics, transplant virology and mycology, and in medical education. He is Past-President of the American Society of Transplantation and a frequent contributor at international symposia. Dr. Fishman's clinical and research interests focus on the pathogenesis and prevention of infection in the immunocompromised host. His laboratory is investigating infectious disease issues related to xenotransplantation and the role of viral infections in transplantation.


Disclosures:

J. Fishman, None

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.